Ovarian Reserve in Beta Thalassemia Major: Implications for Female Fertility and Müllerian Health
International Journal of Drug Delivery Technology · 05.05.2026 · 16 (24s)
DOI: 10.25258/ijddt.16.24s.112 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.05.2026. Verfasst von Manar Ibrahim Hasan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This studytargets to evaluate the impact of Beta Thalassemia Major (BTM) on ovarian reserve and the integrity of the female reproductive system using Anti-Müllerian Hormone (AMH) as a biomarker of fertility potential. The study involved a case-control analysis of transfusion-dependent women with BTM, comparing their hormonal profiles (AMH, TSH, FSH, LH, prolactin, estradiol, testosterone, ferritin) with age-matched healthy controls.Results showed a significant reduction in AMH and other reproductive hormones in the BTM group.There was also a link showing that when ferritin levels are high, AMH levels .tend to be low, suggesting that too much iron can harm ovarian function
Zitieren
APA
Hasan, M. I., Kadhim, H. Y., & ALMahdawi, F. K. I. (2026). Ovarian Reserve in Beta Thalassemia Major: Implications for Female Fertility and Müllerian Health. International Journal of Drug Delivery Technology, 16(24s). https://doi.org/10.25258/ijddt.16.24s.112
Vancouver
Hasan MI, Kadhim HY, ALMahdawi FKI. Ovarian Reserve in Beta Thalassemia Major: Implications for Female Fertility and Müllerian Health. International Journal of Drug Delivery Technology. 2026;16(24s). doi:10.25258/ijddt.16.24s.112
BibTeX
@article{Hasan2026,
author = {Hasan, Manar Ibrahim and Kadhim, Hala Yassen and ALMahdawi, Fatimah Kadhim Ibrahim},
title = {Ovarian Reserve in Beta Thalassemia Major: Implications for Female Fertility and Müllerian Health},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {24s},
doi = {10.25258/ijddt.16.24s.112}
}
EUVIMED